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Abstract
Background: Gene set analysis is a powerful method of deducing biological meaning for an a priori defined set of
genes. Numerous tools have been developed to test statistical enrichment or depletion in specific pathways or
gene ontology (GO) terms. Major difficulties towards biological interpretation are integrating diverse types of
annotation categories and exploring the relationships between annotation terms of similar information.
Results: GARNET (Gene Annotation Relationship NEtwork Tools) is an integrative platform for gene set analysis
with many novel features. It includes tools for retrieval of genes from annotation database, statistical analysis &
visualization of annotation relationships, and managing gene sets. In an effort to allow access to a full spectrum of
amassed biological knowledge, we have integrated a variety of annotation data that include the GO, domain,
disease, drug, chromosomal location, and custom-defined annotations. Diverse types of molecular networks
(pathways, transcription and microRNA regulations, protein-protein interaction) are also included. The pair-wise
relationship between annotation gene sets was calculated using kappa statistics. GARNET consists of three modules
- gene set manager, gene set analysis and gene set retrieval, which are tightly integrated to provide virtually
automatic analysis for gene sets. A dedicated viewer for annotation network has been developed to facilitate
exploration of the related annotations.
Conclusions: GARNET (gene annotation relationship network tools) is an integrative platform for diverse types of
gene set analysis, where complex relationships among gene annotations can be easily explored with an intuitive
network visualization tool (http://garnet.isysbio.org/ or http://ercsb.ewha.ac.kr/garnet/).
Background
Omics studies usually yield a number of gene lists e.g.
differentially expressed genes (DEGs). Typically, a statis-
tical test of enrichment or depletion is performed for an
a priori defined set of genes (usually from clustering of
microarray data) or gene annotations. This approach has
been successfully applied for diverse subjects including
gene ontology (GO), signalling and metabolic pathways,
and identification of regulatory elements such as tran-
scription factors and microRNAs. However, biological
interpretation of gene lists is still a challenge for many
biologists because there is no ‘golden standard method’
established yet. Numerous annotation DBs and tools
have been developed for biological interpretation of
experimental gene lists including but not limited to
GSEA [1], DAVID [2], Gazer [3], FatiGO+ [4], g:Profiler
[5], WebGestalt [6] Lists2Networks [7] and GOAL [8].
A comprehensive list of 68 GSA web tools is recently
reviewed by Huang et al [9] as well as several important
points to consider in using such tools. As Huang and
colleagues suggests, each tool has its own strength and
limitations in terms of statistical method, coverage of
gene annotation types and user interface [9].
O n ei m p o r t a n ti s s u ei nt h ef i e l di st h eg r o w i n gc o m -
plexity of annotation data themselves. The benefit of
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to summarize hundreds or even thousands of genes into
a smaller number of enriched biological themes e.g. GO
term or pathways, allowing simplified interpretation of
high-throughput experiments. However, the analytic
complexity of GSA is getting beyond its benefits because
of the rapid increase of gene annotations e.g. a few doz-
ens of genes can be enriched in a hundred or more anno-
tation terms. The number of GO terms is already more
than the number of genes in a human genome and the
situation is getting similar with other types of annotation
like pathways, the regulatory targets of TFs and miRNA,
disease-associated genes and chromosomal locations
even without considering their combinations [10].
Increasingly, omics data continue to be sources of new
annotations e.g. cancer signature genes from microarray
[11] and disease-associated genes from GWAS studies
[12]. Major difficulties towards meaningful biological
interpretation are integrating diverse types of annotations
and at the same time, handling the complexities for effi-
cient exploration of annotation relationships.
GARNET (Gene Annotation Relationship Network
Tools) is an integrative platform for diverse types of
gene set analysis, allowing convenient annotation net-
work navigation. The utility of GARNET is two-fold.
One is to facilitate the interpretation of gene sets from
high-throughput experiments such as microarray, ChIP-
chip (ChIP-Seq) and high-throughput screening. The
other is to serve as a framework for meta-analysis of
heterogeneous annotations and pre-existing knowledge,
which often lead to novel insights undetectable by indi-
vidual analyses [13]. In an effort to allow access to a full
spectrum of amassed biological knowledge, we have
integrated a variety of annotation data that include the
GO, domain, disease, drug, chromosomal location, and
custom-defined annotations. Diverse types of molecular
networks (pathways, transcription and microRNA regu-
lations) are also included. To deal with the complexity
from a large number of annotations from different cate-
gories, a dedicated annotation network viewer has been
developed for the visualization of related annotations.
GARNET system consists of three modules – gene set
retrieval tool, gene set manager tool,a n dgene set analy-
sis tool, which are tightly integrated to allow access,
manipulation and statistical analysis of pre-compiled
gene annotations and user-defined gene lists. The rela-
tionship between annotation terms is calculated using
Cohen’s kappa statistic. Kappa is less sensitive to the
gene set size than other P-value statistics such as
Chi-square, hypergeometric and binomial test because it
measures the difference between the observed and the
expected agreement between two annotation terms.
Construction and content
System overview
Considering highly exploratory nature of gene set analy-
sis, GARNET is designed to navigate different layers of
gene annotations in a convenient and integrated envir-
onment, equipped with ID conversion module, an inter-
active network viewer and import/export of any gene
sets. GARNET contains four major groups of gene
annotation information – molecular network, gene func-
tion, gene expression, and disease & drugs (Figure 1a).
Molecular network data include pathways, protein-pro-
tein interactions, and microRNA targets from several
different sources. We also included gene annotation
data such as gene ontology, protein domain and chro-
mosomal location as well as differentially expressed
genes (DEGs) from gene expression data. Gene-disease
and gene-drug associations are also complied from rele-
vant sources [14]. Further, any user-defined gene anno-
tation data can be uploaded and analyzed against all the
annotations in the system. The detailed scope of annota-
tion data is provided in Table 1 and on-line.
The GARNET system consists of three main tools –
manager, analysis, and retrieval tools. Figure 1(b) shows
the workflow of GARNET analysis. Users define gene
sets using the manager tool where the set operation is
available to combine two gene sets as union, intersec-
tion, and subtraction. The analysis tool performs enrich-
ment test for the user-supplied genes in the annotation
categories of choice. Multiple test correction is applied
by default since there are so many annotation terms.
The result of statistical analysis is given in table format
where one can access the network view of annotation
terms. In addition to the flat table view, GARNET also
supports the tree view for hierarchical annotations such
as GO and OMIM disease terms. The retrieval tool
allows users to access the annotation database to extract
genes assigned to any annotation term. Importantly,
users may expand their gene list using the molecular
networks in the annotation database. This novel feature
allows users to investigate the down-stream effects of
their genes of interest.
Any gene set analysis requires an ID system. We
chose the Entrez geneID as the reference ID system
instead of devising our own. This alleviates the mainte-
nance (update & expansion) problem significantly since
most annotation databases provide the cross-reference
to the Entrez geneID. GARNET supports most major
gene IDs including Entrez Gene ID, Ensembl Ids (Gene,
Transcript), GenBank, RefSeq, UniProt and microarray
probe IDs (Affymatrix, Illumina). The detailed list of
supported ID types is listed in Table 2. Even though we
support diverse ID types for input, all subsequent
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Page 2 of 8Figure 1 GARNET system overview. a) The annotation categories and types integrated in the GARNET system. b) The schematic overview of
the workflow. The three main modules in the GARNET system are Gene Set Manager Tool, Retrieval Tool and Analysis Tool. The user-supplied
genes are converted to standard gene IDs (Entrez Gene ID) by Manager Tool. A Gene set can be expanded via biological networks in Retrieval
Tool. Analysis Tool performs gene set analysis (GSA) against the GARNET annotations selected by the user.
Table 1 Summary of the annotation categories and types in the GARNET system
Category Annotation DB Number of Annotations Number of Unique Genes Version Update Date
Molecular Network KEGG 199 5193 Release 54.0+/ 2010.05.10
BioCarta 314 1383 2010.04.06
Protein-Protein Interactions (PPI) 5829 7631 NCBI integrated DB 2010.05.17
miRBase 711 34525 5.0 2009.09.29
TarBase 106 394 V5 2008.06
TargetScan 162 7930 4.2
PicTar-4way 178 9152 hg17, Build 35
PicTar-5way 130 3455 hg17, Build 35
Genome Annotation Gene Ontology (GO) 30479 18242 2010.05.20
Pfam domains 3922 16409 24.0 2009.10.07
Chromosomal Bands 3078 32920 2010.05.23
Gene Expression Tissue EST 51 13367 2010.04.06
Tissue SAGE 32 8528 2010.04.06
Tissue Microarray 32 10769
Cancer Microarray 25 13619
Disease & Drug OMIM 1063 2683 2008.08.27
GAD 1212 2872 2008.12.26
DrugBank 591 259
Total 57973 32920
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transcript level.
Datasets
A comprehensive set of gene annotation data are inte-
grated in the GARNET system (Table 1). The annotations
are grouped into four different categories of molecular
network, genome annotation, gene expression, and disease
& drug. The molecular network category consists of path-
ways (KEGG [15], BioCarta), protein-protein interactions
(PPI) from NCBI and four major miRNA target databases
(miRBase [16], TarBase [17], TargetScan [18] and PicTar
[19]). The category of genome annotation contains infor-
mation on gene function (Gene Ontology [20]), protein
domain (Pfam [21]) and chromosomal location. Tissue-
specific or cancer-related gene expression data are
included in the gene expression category. We also col-
lected gene-diesease (OMIM [22], GAD [12]) and gene-
drug association (DrugBank [14]) data from relevant
sources, that are deposited in the disease & drug category.
User interface
Manager Tool
T h eg e n es e tm a n a g e rt o o l( Manager Tool)i st h em a i n
entry point to access all the annotation data and further
gene set analysis in GARNET. The overall workflow is
shown in Figure 2. In Manager Tool, user may create or
delete a new gene set by either entering a list of gene
IDs or uploading an input file. The input gene IDs are
automatically converted to Entrez Gene IDs. All the
Table 2 List of supported ID types in GARNET
Category ID Type Examples
Gene ID Entrez Gene 1457, 2002, 1950
Ensembl Gene ENSG00000101266
Ensembl Transcript ENST00000361797
GenBank Accession AB451279, AI628974
GenBank ID 19769225, 4665774
RefSeq NM_130786, NM_000014
UniGene Hs.41, Hs.56
HGNC Gene Symbol A1BG, A1CF, A2LD1
HGNC Gene ID 7, 8, 7645
Protein ID UniProtKB Accession P62258, Q04917
UniProtKB ID 1433B_HUMAN
PIR Accession S34755, A61235, I38947
Microarray Affymetrix probe ID 212073_at, 210984_x_at
Illumina probe ID 4210086, 2510484
Figure 2 The gene set manager tool.
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named Set Manager Window (dotted red box in Figure
2), where the gene set of interest can be chosen. Users
can access the member genes of the chosen gene set or
create a new gene set by set operation of existing gene
sets e.g. interaction, subtraction, and union. Once gene
sets are prepared in the Manager Tool, user can proceed
to Analysis Tool for gene set analysis or Retrieval Tool
for expanding gene list along the biological networks as
described in the later sections.
Analysis Tool
Analysis Tool implements the core function of statistical
over-representation analysis against various types of
gene annotations. User selects a target gene set and can
perform GSA against multiple types of annotations
simultaneously. The overall procedure of GSA is shown
in Figure 3. Kappa statistic is used as the enrichment
score in GARNET. Multiple test correction is done by
Benjamini-Hochberg method. The stringency of GSA is
set as q-value<0.05 by default, but the q-value cut-off
can be adjusted according to the user’s preference as
well as by the number of hit annotations. As a result of
GSA, the list of significantly enriched annotations is dis-
played as table view. Particularly, the relationships
among the enriched annotations are presented in an
interactive network viewer. The annotation network
data are downloadable in standard formats for other
visualization tools (e.g. cytoscape) or network clustering
softwares (e.g. MCL [23]) for further analysis. It also
opens the chance to reveal connections among hetero-
geneous types of annotations e.g. miRNA targets and
cancer signature genes, drug targets and protein. Anno-
tations such as Gene Ontology and MeSH terms have
hierarchical structure, which is displayed in tree view as
well (top-left in Figure 3).
Retrieval Tool
Retrieval Tool is for getting the member gene list of
existing annotations and for expanding the existing
gene sets via various types of biological networks. For
example, miRNA target genes can be expanded via
Figure 3 The gene set analysis tool.
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network and so on (Figure 4). Gene set expansion via
networks can be useful in combination with set opera-
tions e.g. intersection and difference in the Manager
Tool, allowing a great freedom to navigate and com-
bine the different aspects of existing knowledge. All
the gene sets in GARNET is accessible by keyword or
ID search and the member genes are listed in the
resulting page (Figure 5).
Conclusions
GARNET (gene annotation relationship network tools)
is an integrative platform for diverse types of gene set
analysis, where complex relationships among gene anno-
tations can be easily explored with an intuitive network
visualization tool.
Availability and requirements
GARNET is available at http://garnet.isysbio.org/ and
http://ercsb.ewha.ac.kr/garnet/.
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